Measures · D03 in 2019 · Part D · DD1 Drug Plan Customer Service
Appeals Upheld
AppealsDrug PlanSource: Independent Review Entity
- What it measures
- How often an independent reviewer thought the drug plan’s decision to deny an appeal was fair. This includes appeals made by plan members and out-of-network providers. (This rating is not based on how often the plan denies appeals, but rather how fair the plan is when they deny an appeal.)
- How it's calculated
- This measure is defined as the percent of IRE confirmations of upholding the plans’ decisions. This is calculated as: [(Number of cases upheld) / (Total number of cases reviewed)] * 100. Total number of cases reviewed is defined all cases received by the IRE during the timeframe and receiving a decision before May 1, 2018. The denominator is equal to the number of cases upheld, fully reversed, and partially reversed. Dismissed, remanded, and withdrawn cases are not included in the denominator. Auto-forwarded cases are included, as these are considered to be adverse decisions per Subpart M rules. If a Reopening occurs and is decided prior to May 1, 2018, the Reopened decision is used in place of the Reconsideration decision. Reopenings decided on or after May 1, 2018 are not reflected in these data, the original decision result is used. The results of appeals that occur beyond Level 2 (i.e., Administrative Law Judge or Medicare Appeals Council appeals) are not included in the data. Contracts with no IRE cases reviewed will not receive a score in this measure.
- Data source
- Independent Review Entity (IRE) Data were obtained from the Independent Review Entity (IRE) contracted by CMS for Part D reconsiderations. The appeals used in this measure are based on the date they were received by the IRE, not the date a decision was reached by the IRE.
- Measurement period
- 01/01/2017 – 12/31/2017
- Better when
- Higher
- Weight
- 1.5 (Measures Capturing Access)
- Star assignment
- Clustering
- Case-mix adjusted
- —
- In improvement measure
- Yes
- Used in CAI
- No
- Exclusions
Show
Contracts with fewer than 10 cases reviewed by the IRE.- Disaster policy
- Higher measure star (2018-2019) for contracts with 25% or more enrolled affected
From the 2019 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts.
2019 star distribution
Not rated: Not enough data available (297); No data available (130); Plan not required to report measure (11)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2021 | MA-PD | < 79 % | >= 79 % to < 85 % | >= 85 % to < 89 % | >= 89 % to < 95 % | >= 95 % |
| 2021 | PDP | < 80 % | >= 80 % to < 87 % | >= 87 % to < 93 % | >= 93 % to < 97 % | >= 97 % |
| 2020 | MA-PD | < 71% | ? 71% to < 78% | ? 78% to < 86% | ? 86% to < 94% | ? 94% |
| 2020 | PDP | < 80% | ? 80% to < 84% | ? 84% to < 90% | ? 90% to < 94% | ? 94% |
| 2019 | MA-PD | < 60% | ? 60% to < 69% | ? 69% to < 81% | ? 81% to < 92% | ? 92% |
| 2019 | PDP | < 64% | ? 64% to < 78% | ? 78% to < 89% | ? 89% to < 91% | ? 91% |
| 2018 | MA-PD | < 56% | ? 56% to < 71% | ? 71% to < 79% | ? 79% to < 89% | ? 89% |
| 2018 | PDP | < 61% | ? 61% to < 71% | ? 71% to < 81% | ? 81% to < 92% | ? 92% |
| 2017 | MA-PD | < 47% | ? 47% to < 66% | ? 66% to < 78% | ? 78% to < 88% | ? 88% |
| 2017 | PDP | < 60% | ? 60% to < 66% | ? 66% to < 77% | ? 77% to < 91% | ? 91% |
| 2016 | MA-PD | < 42% | ? 42% to < 60% | ? 60% to < 73% | ? 73% to < 88% | ? 88% |
| 2016 | PDP | < 54% | ? 54% to < 65% | ? 65% to < 76% | ? 76% to < 91% | ? 91% |
| 2015 | MA-PD | < 50% | ? 50% to < 60% | ? 60% to < 72% | ? 72% to < 84% | ? 84% |
| 2015 | PDP | < 48% | ? 48% to < 58% | ? 58% to < 68% | ? 68% to < 78% | ? 78% |
Lowest-scoring contracts, 2019
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H6815 Wellcare | Centene Corporation | 12,439 | 33 | 1 | −3 | 48 | 0% |
| S3875 Granite Alliance | Prime Therapeutics, LLC. | 0 | 53 | 1 | −1 | 36 | 0% |
| H5050 Kaiser Permanente | Kaiser Foundation Health Plan, Inc. | 99,167 | 50 | 1 | −1 | 31 | 1% |
| H5587 Blue Cross Blue Shield of Arizona Health Choice | Blue Cross Blue Shield of Arizona | 8,603 | 50 | 1 | — | 31 | 1% |
| H9808 HealthTeam Advantage | Risant Health, Inc. | 19,139 | 50 | 1 | −2 | 31 | 1% |
| H7917 BlueCross BlueShield of Tennessee | BlueCross BlueShield of Tennessee | 189,267 | 51 | 1 | −3 | 30 | 2% |
| H3259 BlueCare Plus Tennessee | BlueCross BlueShield of Tennessee | 31,617 | 54 | 1 | — | 27 | 3% |
| S5975 Moda Health Plan, Inc. | Moda Partners, Inc. | 58,300 | 54 | 1 | −1 | 35 | 3% |
| H7787 HealthSpring | Health Care Service Corporation | 17,914 | 60 | 2 | −2 | 21 | 3% |
| H2241 Golden State | MacArthur Court Acquisition Corp | — | 60 | 2 | −2 | 21 | 3% |
| H5106 Highmark Blue Cross Blue Shield | Highmark Health | 16,043 | 60 | 2 | 0 | 21 | 3% |
| H7020 HealthSpring | Health Care Service Corporation | 15,661 | 61 | 2 | 0 | 20 | 5% |
| H3813 Moda Health Plan, Inc. | Moda Partners, Inc. | — | 61 | 2 | 0 | 20 | 5% |
| S0655 Tufts Health Plan | Point32Health, Inc. | — | 64 | 2 | 0 | 25 | 6% |
| H0354 HealthSpring | Health Care Service Corporation | 75,493 | 62 | 2 | 0 | 19 | 6% |
| H3154 Horizon Blue Cross Blue Shield of New Jersey | Horizon Healthcare Services, Inc. | — | 63 | 2 | −2 | 18 | 7% |
| H3388 CDPHP Medicare Advantage | Lifetime Healthcare, Inc. | 69,842 | 64 | 2 | — | 17 | 7% |
| H3204 Presbyterian Health Plan | Presbyterian Healthcare Services | 52,025 | 65 | 2 | 0 | 16 | 8% |
| H0562 Wellcare | Centene Corporation | 23,649 | 67 | 2 | 0 | 14 | 8% |
| S9701 Navitus MedicareRx | Medica Holding Company | 102,337 | 65 | 1 | −1 | 24 | 8% |
| H1994 Select Health | Intermountain Health Care, Inc. | 67,364 | 69 | 3 | −1 | 12 | 9% |
| H5410 HealthSpring | Health Care Service Corporation | 15,658 | 69 | 3 | +1 | 12 | 9% |
| H9725 HealthSpring | Health Care Service Corporation | 33,438 | 69 | 2 | 0 | 12 | 9% |
| H4407 HealthSpring | Health Care Service Corporation | 14,551 | 70 | 3 | −1 | 11 | 10% |
| H3054 Constellation Health, Llc. | Constellation Health, LLC. | — | 70 | 2 | 0 | 11 | 10% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2021 | D03 | Appeals Upheld | 01/01/2019 – 12/31/2019 | 2 | Independent Review Entity |
| 2020 | D03 | Appeals Upheld | 01/01/2018– 12/31/2018 | 1.5 | Independent Review Entity |
| 2019 | D03 | Appeals Upheld | 01/01/2017 – 12/31/2017 | 1.5 | Independent Review Entity |
| 2018 | D03 | Appeals Upheld | 01/01/2016 – 12/31/2016 | 1.5 | Independent Review Entity |
| 2017 | D03 | Appeals Upheld | 01/01/2015 - 12/31/2015 | 1.5 | Independent Review Entity |
| 2016 | D03 | Appeals Upheld | 01/01/2014 - 12/31/2014 | 1.5 | Independent Review Entity |
| 2015 | D02 | Appeals Upheld | 01/01/2014 - 06/30/2014 | 1.5 | Independent Review Entity |